Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma.
Gerstner
E R
ER
Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA. egerstner@partners.org
Yip
S
S
Wang
D L
DL
Louis
D N
DN
Iafrate
A J
AJ
Batchelor
T T
TT
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics* / Q000378:metabolism; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism; D019175:DNA Methylation; D005260:Female; D005909:Glioblastoma / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008297:Male; D019853:O(6)-Methylguanine-DNA Methyltransferase / Q000235:genetics* / Q000378:metabolism; D011237:Predictive Value of Tests; D011379:Prognosis
D014408:Biomarkers, Tumor; D019853:O(6)-Methylguanine-DNA Methyltransferase